Grey zone between narcolepsy type 1 and type 2

CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2017; 75(09): 682-683
DOI: 10.1590/0004-282X20170106

OPINIONS

Zona cinzenta entre narcolepsia tipo 1 e tipo 2

Authors

Gustavo Bruniera Fernandes

¹Univesidade Federal de São Paulo, Departamento de Psicobiologia, São Paulo SP, Brasil;
Renata Carvalho Cremaschi

¹Univesidade Federal de São Paulo, Departamento de Psicobiologia, São Paulo SP, Brasil;
Sérgio Tufik

¹Univesidade Federal de São Paulo, Departamento de Psicobiologia, São Paulo SP, Brasil;
Fernando Morgadinho Coelho

¹Univesidade Federal de São Paulo, Departamento de Psicobiologia, São Paulo SP, Brasil;

²Univesidade Federal de São Paulo, Departamento de Neurologia, São Paulo SP, Brasil.

References
1 Ruoff C, Rye D. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality. Curr Med Res Opin. 2016: 1-12.
2 Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002;59(10):1553-62. https://doi.org/10.1001/archneur.59.10.1553
3 Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;355(9197):39-40. https://doi.org/10.1016/S0140-6736(99)05582-8
4 Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, Vankova J et al. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy Ann Neurol. 2001;50(3):381-8. https://doi.org/10.1002/ana.1130
5 Barateau L, Lopez R, Arnulf I, Lecendreux M, Franco P, Drouot X et al. Comorbidity between central disorders of hypersomnolence and immune-based disorders. Neurology. 2017;88(1):93-100. https://doi.org/10.1212/WNL.20170106201701063432